Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quali-SAT: Transferrin Saturation Guided Maintenance Treatment in HFE Haemochromatosis
NCT04779593Active, not recruiting
- Sponsor
- CHU Rennes
- Start
- Jul 2021
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in Hemochromatosis (2 arms), sponsored by CHU Rennes. Primary endpoint: Physical Component Score of the SF-36 questionnaire at 24 months. Started Jul 2021; status: active, not recruiting.
02
Conditions
Hemochromatosis
Beyond the preview
Go deeper on NCT04779593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04779593.